A review on Congenital Adrenal Hyperplasia andits management

This is the authors' abstract. We don't add key points for this paper.

A collection of hereditary conditions known as Congenital Adrenal Hyperplasia (CAH) impact adrenal steroidogenesis, resulting in an excess of androgens and a shortage of cortisol and, frequently, aldosterone synthesis. The goal of this study is to present a thorough overview of CAH, with particular attention to its genetic foundation, clinical symptoms, diagnostic methodologies, and therapeutic techniques. The etiology of the disorder is mostlyassociated with mutations in the CYP21A2 gene, which codes for the 21-hydroxylase enzyme. Clinically, CAH canappear in a range of severity states, from milder, non-classic variants that emerge later in life to life-threatening salt- wasting crises in infancy.Biochemical tests and genetic testing are used to confirm the diagnosis. A comprehensivestrategy is needed to manage CAH, including regular psychosocial support, surgical correction of genital abnormalities, and replenishment of glucocorticoids and mineralocorticoids. There is also discussion of newtherapeutic techniques including gene therapy and recent developments in prenatal diagnosis and treatment. In order to enhance outcomes and quality of life for people with CAH, this review emphasizes the significance of earlydiagnosis, customized treatment strategies, and ongoing monitoring.